Translation News and Research

RSS

Fox Chase announces posting of clinical outcomes data to its website for patient use

Fox Chase Cancer Center, one of the nation's leading cancer research and treatment institutions, today announced the posting of clinical outcomes data to its website as a tool to assist newly-diagnosed patients in deciding where to seek cancer care.

1 Feb 2011

Researchers discover 'common set of dysregulated miRNAs in murine lupus models'

Potentially impacting future diagnosis and treatment of lupus, an immune illness affecting more than 5 million people worldwide, researchers at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech have likely uncovered where the breakdown in the body's lymphocyte molecular regulatory machinery is occurring.

1 Feb 2011

Avantra Biosciences selects TGen Drug Development for new biomarker quantitation platform

Avantra Biosciences today announced the selection of TGen Drug Development as a key test site for Avantra's new biomarker quantitation platform.

1 Feb 2011

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

ImaginAb, and Eurogentec S.A. announce a development collaboration to establish a novel system for producing engineered antibody fragments. The two companies will produce ImaginAb's optimized antibody fragments with Eurogentec's high-performance Pichia pastoris expression system.

1 Feb 2011

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital Association annual survey.

29 Jan 2011

Zimmer fourth quarter net sales increase 2.5% to $1.13 billion

Zimmer Holdings, Inc. today reported financial results for the quarter and year ended December 31, 2010. The Company reported fourth quarter net sales of $1.13 billion, an increase of 2.5% reported and 3.0% constant currency over the fourth quarter of 2009.

27 Jan 2011

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

HTX announced today an agreement to establish GE's first global Pathology Imaging Centre of Excellence in Toronto, Ontario. GE Healthcare and its digital pathology joint venture, Omnyx™, will invest $7.75M along with a $2.25M grant from the Health Technology Exchange (HTX). Planned collaborative research and development (R&D) partnerships will bring an additional $7.2M, for a total investment of $17.2M over the next 3 years.

27 Jan 2011

Waters fourth quarter sales increase 13% to $484 million

Waters Corporation reported fourth quarter 2010 sales of $484 million, an increase of 13% from sales of $429 million in the fourth quarter of 2009. In the quarter, foreign currency translation was about neutral to sales growth. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.36 compared to $1.08 for the fourth quarter of 2009.

25 Jan 2011

SNM commends FDA Advisory Committee recommendation for florbetapir approval

The Society of Nuclear Medicine (SNM) commends the U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee on its recent recommendation for conditional approval of a new imaging agent, florbetapir.

25 Jan 2011

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

Health care systems around the world are failing to use evidence obtained through research when making decisions, causing inefficiencies and reduced quantity and quality of life, according to a leading expert in the field of "knowledge translation."

20 Jan 2011

National Jewish Health issued method patent for desensitizing B cells

National Jewish Health has been issued a US patent claiming a method to desensitize B cells by inactivating antigen receptors on their surfaces. The method, discovered by John Cambier, PhD, Chairman of the Integrated Department of Immunology at National Jewish Health, holds promise for treatment of B-cell mediated diseases, such as lymphoma and leukemia, rheumatoid arthritis, lupus and rejection of organ transplants.

19 Jan 2011

ICON announces acquisition of Oxford Outcomes

ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the expansion of its Late Phase and Outcomes Research services through the acquisition of Oxford Outcomes, a leading international health outcomes consultancy.

14 Jan 2011

Sanofi-aventis, UCSF announce research and development collaborations

Sanofi-aventis and the University of California, San Francisco (UCSF) announced today that they have formed two research and development collaborations that join together leaders from academia and industry to more rapidly advance groundbreaking innovation from the lab to the patient.

13 Jan 2011

SRI International receives $17.4 million grant to boost treatments for cardiovascular, lung, blood diseases

SRI International, an independent nonprofit research and development organization, announced today that it has been awarded two preclinical services contracts totaling $17.4 million by the National Heart, Lung, and Blood Institute, one of the National Institutes of Health.

13 Jan 2011

Study supports use of telomerase inhibitors for treatment of childhood cancers

Geron Corporation today announced the publication of preclinical data demonstrating that the company's telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical trials, selectively targets cancer stem cells in pediatric tumors of neural origin.

11 Jan 2011

Research suggests novel therapeutic approach for Huntington's Disease

Hope for new ways of treating devastating neurodegenerative disorders such as Huntington's disease has been raised by a trans-Atlantic team of researchers thanks to the use of cutting-edge genetic techniques.

10 Jan 2011

Researchers demystify death of brain cells in Parkinson's patients

Just 5 percent of Parkinson's disease cases can be explained by genetic mutation, while the rest have no known cause. But a new discovery by researchers at The University of Texas Health Science Center San Antonio may begin to explain why the vast majority of Parkinson's patients develop the progressive neurodegenerative disease.

10 Jan 2011

Alnylam presents ALN-VSP Phase I trial results for liver cancer

Alnylam Pharmaceuticals, a leading RNAi therapeutics company, today presented new clinical data from its ALN-VSP Phase I liver cancer trial in a presentation at the Dana-Farber Cancer Institute in Boston. Results from molecular analysis of human biopsy samples showed achievement of pharmacologically relevant siRNA drug levels in tissues.

5 Jan 2011

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

Advanced Cell Technology, a leader in the field of regenerative medicine, announced today that it has entered into a Memorandum of Understanding with Roslin Cells LTD of Scotland, in which the two companies contemplate a definitive collaboration agreement in the near future.

28 Dec 2010

Demand for medical interpreters to increase in the new year

As the number of non-English speakers seeking healthcare in the United States continues to grow, so does the need for medical interpreters who can serve as a liaison between patients and their doctors. The demand for medical interpreters is expected to increase even more when new standards go into effect on January 1, 2011 requiring healthcare organizations to provide an interpreter to patients who speak limited English.

24 Dec 2010

Translation News and Research

Fox Chase announces posting of clinical outcomes data to its website for patient use

Researchers discover 'common set of dysregulated miRNAs in murine lupus models'

Avantra Biosciences selects TGen Drug Development for new biomarker quantitation platform

Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments

Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of preventive care

Zimmer fourth quarter net sales increase 2.5% to $1.13 billion

GE's Pathology Imaging Centre of Excellence receives HTX investment under Ontario Flagship Program

Waters fourth quarter sales increase 13% to $484 million

SNM commends FDA Advisory Committee recommendation for florbetapir approval

Failure to use research evidence leads to inefficiencies, reduced quality of life, says Dr. Sharon

National Jewish Health issued method patent for desensitizing B cells

ICON announces acquisition of Oxford Outcomes

Sanofi-aventis, UCSF announce research and development collaborations

SRI International receives $17.4 million grant to boost treatments for cardiovascular, lung, blood diseases

Study supports use of telomerase inhibitors for treatment of childhood cancers

Research suggests novel therapeutic approach for Huntington's Disease

Researchers demystify death of brain cells in Parkinson's patients

Alnylam presents ALN-VSP Phase I trial results for liver cancer

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

Demand for medical interpreters to increase in the new year

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News